Literature DB >> 21620712

DOTA derivatives for site-specific biomolecule-modification via click chemistry: synthesis and comparison of reaction characteristics.

Carmen Wängler1, Martin Schäfer, Ralf Schirrmacher, Peter Bartenstein, Björn Wängler.   

Abstract

Due to the high stability of its complexes with many M(2+) and M(3+)-ions, DOTA (1,4,7,10-tetraazacyclododecane-N,N',N″,N‴-tetraacetic acid) is the most commonly used chelator for the derivatization and radiolabeling of bioactive molecules. Most of the currently used DOTA derivatives comprise amine-reactive functionalities, limiting their application to the derivatization of fully protected molecules or otherwise resulting in randomly distributed conjugation sites of undefined number. Click chemistry reactions are a valuable alternative to this unspecific conjugation as they proceed efficiently and chemoselectively under mild conditions allowing a site-specific derivatization of unprotected biomolecules. In this work, we describe straightforward syntheses of DOTA derivatives containing thiol, maleimide, aminooxy, aldehyde, alkyne, and azide functionalities, amenable to the currently most often used click chemistry reactions. Furthermore, the efficiency of the respective click reactions introducing DOTA into bioactive molecules was investigated. For each of the synthesized DOTA synthons, the site-specific and efficient conjugation to Tyr(3)-octreotate could be shown. Among these, the addition and oxime formation reactions proceeded fast and without side reactions, giving the products in high yields of 64-83% after purification. The copper-catalyzed triazole formation reactions produced some side-products, giving the desired products in lower, but still reasonable overall yields of 19-25%. All synthesized peptide-DOTA-conjugates were labeled with (68)Ga in high radiochemical yields of 96-99% and high specific activities providing compounds of high purity, demonstrating the applicability of all synthons for biomolecule modification and subsequent radiolabeling.
Copyright © 2011. Published by Elsevier Ltd.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21620712     DOI: 10.1016/j.bmc.2010.12.047

Source DB:  PubMed          Journal:  Bioorg Med Chem        ISSN: 0968-0896            Impact factor:   3.641


  4 in total

1.  (111)In- and (203)Pb-Labeled Cyclic RGD Peptide Conjugate as an α(v)β(3) Integrin-Binding Radiotracer.

Authors:  Kido Nwe; Young-Seung Kim; Diane E Milenic; Kwamena E Baidoo; Martin W Brechbiel
Journal:  J Labelled Comp Radiopharm       Date:  2012-09-05       Impact factor: 1.921

Review 2.  Evidence-based information on the clinical use of neurofeedback for ADHD.

Authors:  Tais S Moriyama; Guilherme Polanczyk; Arthur Caye; Tobias Banaschewski; Daniel Brandeis; Luis A Rohde
Journal:  Neurotherapeutics       Date:  2012-07       Impact factor: 7.620

3.  Development of a Click-Chemistry Reagent Compatible with Mass Cytometry.

Authors:  Jessica Shaklee; Kriti Srivastava; Heather Brown; Edgar A Arriaga; Valerie C Pierre; Jop H van Berlo
Journal:  Sci Rep       Date:  2018-04-27       Impact factor: 4.379

Review 4.  89Zr-Immuno-Positron Emission Tomography in Oncology: State-of-the-Art 89Zr Radiochemistry.

Authors:  Sandra Heskamp; René Raavé; Otto Boerman; Mark Rijpkema; Victor Goncalves; Franck Denat
Journal:  Bioconjug Chem       Date:  2017-08-24       Impact factor: 4.774

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.